Scan to download
BTC $66,814.03 +0.22%
ETH $2,064.58 +0.75%
BNB $586.30 -0.65%
XRP $1.32 +0.37%
SOL $79.61 +0.63%
TRX $0.3149 -0.18%
DOGE $0.0911 +1.22%
ADA $0.2443 +2.65%
BCH $444.32 +0.60%
LINK $8.72 +1.95%
HYPE $35.76 +1.74%
AAVE $95.25 +1.03%
SUI $0.8713 +0.94%
XLM $0.1656 +1.18%
ZEC $237.44 -0.00%
BTC $66,814.03 +0.22%
ETH $2,064.58 +0.75%
BNB $586.30 -0.65%
XRP $1.32 +0.37%
SOL $79.61 +0.63%
TRX $0.3149 -0.18%
DOGE $0.0911 +1.22%
ADA $0.2443 +2.65%
BCH $444.32 +0.60%
LINK $8.72 +1.95%
HYPE $35.76 +1.74%
AAVE $95.25 +1.03%
SUI $0.8713 +0.94%
XLM $0.1656 +1.18%
ZEC $237.44 -0.00%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.